A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Alterome Therapeutics, Inc.
Daiichi Sankyo
Pfizer
Nuvectis Pharma, Inc.
ViroMissile, Inc.
Replimune Inc.
Pfizer
Astellas Pharma Inc
AstraZeneca
Amgen
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Werewolf Therapeutics, Inc.
Iambic Therapeutics, Inc
Pheon Therapeutics
Pheon Therapeutics
Boehringer Ingelheim
AgonOx, Inc.
Novartis
Calico Life Sciences LLC
GlaxoSmithKline
Sairopa B.V.
Bristol-Myers Squibb
AbbVie
Tesaro, Inc.
AstraZeneca
AstraZeneca
Amgen
AstraZeneca
University of California, San Diego
Boehringer Ingelheim
Coherus Oncology, Inc.
Stanford University
Tesaro, Inc.
Rondo Therapeutics
Pfizer
AbbVie
Hummingbird Bioscience
Turning Point Therapeutics, Inc.
HUYABIO International, LLC.
HUYABIO International, LLC.
National Institutes of Health Clinical Center (CC)
Pfizer
Sanofi
Nurix Therapeutics, Inc.
JS InnoPharm, LLC